Factor XIa Inhibitor (Bayer)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFactor XIa Inhibitor (Bayer)
Drug Alias NameFactor XIa Inhibitor (Bayer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsBlood Coagulation Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsBlood Coagulation Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A